Your browser doesn't support javascript.
loading
Autoimmune polyendocrine syndrome type 2 in patient with severe allergic asthma treated with omalizumab.
Rams, Anna; Zólcinski, Marek; Zastrzezynska, Weronika; Polanski, Stanislaw; Serafin, Agnieszka; Wilanska, Joanna; Musial, Jacek; Bazan-Socha, Stanislawa.
Affiliation
  • Rams A; a Department of Internal Medicine , Jagiellonian University Medical College , Krakow , Poland.
  • Zólcinski M; a Department of Internal Medicine , Jagiellonian University Medical College , Krakow , Poland.
  • Zastrzezynska W; a Department of Internal Medicine , Jagiellonian University Medical College , Krakow , Poland.
  • Polanski S; a Department of Internal Medicine , Jagiellonian University Medical College , Krakow , Poland.
  • Serafin A; a Department of Internal Medicine , Jagiellonian University Medical College , Krakow , Poland.
  • Wilanska J; a Department of Internal Medicine , Jagiellonian University Medical College , Krakow , Poland.
  • Musial J; a Department of Internal Medicine , Jagiellonian University Medical College , Krakow , Poland.
  • Bazan-Socha S; a Department of Internal Medicine , Jagiellonian University Medical College , Krakow , Poland.
J Asthma ; 55(12): 1384-1386, 2018 12.
Article in En | MEDLINE | ID: mdl-29300536

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asthma / Polyendocrinopathies, Autoimmune / Anti-Asthmatic Agents / Omalizumab / Hypersensitivity, Immediate Limits: Female / Humans / Middle aged Language: En Journal: J Asthma Year: 2018 Type: Article Affiliation country: Poland

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Asthma / Polyendocrinopathies, Autoimmune / Anti-Asthmatic Agents / Omalizumab / Hypersensitivity, Immediate Limits: Female / Humans / Middle aged Language: En Journal: J Asthma Year: 2018 Type: Article Affiliation country: Poland